Use of intranasal luteinizing hormone-releasing hormone agonist in uterine leiomyomas
- 1 February 1987
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 47 (2) , 229-233
- https://doi.org/10.1016/s0015-0282(16)49996-6
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Luteinizing hormone-releasing hormone agonist and uterine leiomyoma: A pilot studyAmerican Journal of Obstetrics and Gynecology, 1985
- Regression of leiomyomata uteri following hypoestrogenism induced by repetitive luteinizing hormone-releasing hormone agonist treatment: preliminary reportFertility and Sterility, 1984
- Confirmation of the preoperative diagnoses for hysterectomyAmerican Journal of Obstetrics and Gynecology, 1984
- Sensitivity of pituitary and corpus luteum responses to single intranasal administration of (d-Ser[TBU]6-des-Gly-NH210) luteinizing hormone-releasing hormone ethylamide (Buserelin) in normal womenFertility and Sterility, 1982
- Uterine leiomyomata: etiology, symptomatology, and managementFertility and Sterility, 1981